Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating hepatitis b cirrhosis

A drug and hepatitis B technology, applied in the field of drugs for the treatment of hepatitis B cirrhosis, can solve problems such as insufficient curative effect, and achieve the effect of no side effects, significant effect, and good effect.

Inactive Publication Date: 2014-12-03
QINGDAO MUNICIPAL HOSPITAL
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine mainly uses antiviral and antihepatic fibrosis drugs for the treatment of hepatitis B cirrhosis, but the curative effect is not satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating hepatitis b cirrhosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A medicine for treating hepatitis B cirrhosis, in parts by weight, its specific component content is as follows:

[0038] 40 parts of Evodia rutaecarpa, 100 parts of angelica, 100 parts of Chuanqiong, 280 parts of rehmannia glutinosa, 100 parts of white peony root, 280 parts of cooked rhubarb, 40 parts of leech (made), 40 parts of horsefly (deleted, fried), 40 parts of scutellaria baicalensis, 100 parts of Guizhi, 100 parts of Poria cocos, 40 parts of fried Atractylodes macrocephala, 100 parts of peach kernels, 100 parts of bitter almonds (stir-fried), 110 parts of red ginseng, 100 parts of dried ginger, 40 parts of Radix Aconiti, 80 parts of moxibustion licorice.

[0039] The specific preparation method is as follows:

[0040] 1), weigh the drug according to the weight portion, soak in clear water for 2 hours, add 13 to 17 times the weight of water to decoct for 2.5 to 3.5 hours, filter and centrifuge to remove residue, and concentrate into a clear paste; 2), the clear...

Embodiment 2

[0042] A medicine for treating hepatitis B cirrhosis, in the pharmaceutical composition, the content of its specific components is as follows in parts by weight:

[0043] 80 parts of evodia, 130 parts of angelica, 130 parts of Chuanqiong, 320 parts of rehmannia glutinosa, 130 parts of white peony root, 320 parts of cooked rhubarb, 80 parts of leech (made), 80 parts of horsefly (fried), 80 parts of scutellaria baicalensis, 130 parts of Guizhi, 140 parts of Poria cocos, 80 parts of fried Atractylodes macrocephala, 140 parts of peach kernel, 130 parts of bitter almond (stir-fried), 120 parts of red ginseng, 130 parts of dried ginger, 80 parts of Radix Aconiti, 100 parts of moxibustion licorice. The specific preparation method is as follows:

[0044] With embodiment 1.

Embodiment 3

[0046] A medicine for treating hepatitis B cirrhosis, in the pharmaceutical composition, the content of its specific components is as follows in parts by weight:

[0047] 50 parts of Evodia rutaecarpa, 110 parts of angelica, 110 parts of Chuanqiong, 290 parts of rehmannia glutinosa, 110 parts of white peony root, 290 parts of cooked rhubarb, 50 parts of leech (made), 50 parts of horsefly (deleted and fried), 50 parts of scutellaria baicalensis, 110 parts of Guizhi, 110 parts of Poria cocos, 50 parts of fried Atractylodes macrocephala, 110 parts of peach kernel, 110 parts of bitter almond (stir-fried), 110 parts of red ginseng, 110 parts of dried ginger, 60 parts of Radix Aconiti, 90 parts of moxibustion licorice.

[0048] The specific preparation method is as follows:

[0049] With embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicine for treating hepatitis b cirrhosis. The medicine is prepared from the following components: fructus evodiae, angelica sinensis, sichuan lovage rhizome, radix rehmanniae, radix paeoniae alba, cooked rhubarb, leech (prepared), gadfly (wings and feet removed, fried), scutellaria baicalensis, cassia twig, poria, roasted rhizoma atractylodis macrocephalae, peach kernel, bitter apricot kernel (fried), red ginseng, dried ginger, aconitum vilmorinianum kom and radix glycyrrhizae preparata. The medicine has the effects of nourishing yin and clearing heat, activating blood circulation to remove stasis, dredging channels and eliminating masses, can achieve the effect of treating both symptoms and root causes of hepatitis b cirrhosis and eliminating clinical symptoms to finally achieve the aim of healing. Furthermore, the medicine is combined by medicines with an inflammation-diminishing effect and medicines with effects of protecting liver, dredging channels and nourishing yin, and has an excellent effect on patients with hepatitis b cirrhosis in different courses. The medicine composition has a remarkable effect for treating hepatitis b cirrhosis and does not have side effect.

Description

technical field [0001] The invention relates to a medicine for treating hepatitis B cirrhosis. Background technique [0002] Liver cirrhosis is a chronic liver disease characterized by diffuse fibrosis, pseudolobules and regenerative nodules in liver tissue. It is a common clinically intractable disease with a high mortality rate. In my country, the common cause of cirrhosis is chronic viral hepatitis, especially chronic hepatitis B. The chronicity of viral hepatitis can easily lead to hepatic hypertrophy, and liver fibrosis, even the result of chronic hepatitis, may be the pathological cause of the occurrence and development of liver cirrhosis. [0003] At present, Western medicine mainly adopts antiviral and antihepatic fibrosis drugs for the treatment of hepatitis B cirrhosis, but the curative effect is not satisfactory. Contents of the invention [0004] In order to obtain a new efficient and safe drug applicable to the treatment of thrombocytopenia caused by radioth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P1/16A61P31/20A61K35/64A61K35/62
Inventor 栾绍海孙昕张巍巍孟欣颖
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com